Elevance Health Inc/ US0367521038 /
| 27.12.2024 21:55:08 | Diff. -2,8300 | Volumen | Geld27.12.2024 | Brief27.12.2024 | Marktkapitalisierung | Dividendenr. | KGV |
|---|---|---|---|---|---|---|---|
| 370,8300USD | -0,76% | 507.086 Umsatz: 109,05 Mio. |
370,6800Geld Vol: 800 | 371,0200Brief Vol: 800 | 85,76 Mrd.USD | 1,60% | 14,57 |
Aktiva
| 2014 US GAAP in Mio. USD |
2015 US GAAP in Mio. USD |
2016 US GAAP in Mio. USD |
2017 US GAAP in Mio. USD |
2018 US GAAP in Mio. USD |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sachanlagen | 1.944,3000 | 2.019,8000 | 1.977,9000 | 2.174,9000 | 2.735 | ||||||
| Immaterielle Vermögensgegenstände | 7.958,1000 | 8.158 | 7.964,9000 | 8.368,4000 | 9.007 | ||||||
| Finanzanlagen | 2.231,8000 | 2.630,3000 | 2.796,3000 | 3.937,4000 | 4.213 | ||||||
| Anlagevermögen | 29.836,1000 | 30.855,7000 | 30.768,2000 | 34.277,2000 | 37.250 | ||||||
| Vorräte | - | - | - | - | - | ||||||
| Forderungen | - | 11.943,6000 | 14.426,9000 | 14.978,2000 | 9.311 | ||||||
| Liquide Mitteln | 2.151,7000 | 2.113,5000 | 4.075,3000 | 3.608,9000 | 3.934 | ||||||
| Umlaufvermögen | 32.228,9000 | 30.862,1000 | 34.314,9000 | 36.262,8000 | 34.321 | ||||||
| Aktiva, gesamt | 62.065 | 61.717,8000 | 65.083,1000 | 70.540 | 71.571 | ||||||
Passiva
| 2014 US GAAP in Mio. USD |
2015 US GAAP in Mio. USD |
2016 US GAAP in Mio. USD |
2017 US GAAP in Mio. USD |
2018 US GAAP in Mio. USD |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Verbindlichkeiten aus Lieferungen und Leistungen | - | 10.888,6000 | 11.907,5000 | 13.015,9000 | 12.413 | ||||||
| Langfristige Schulden | 14.127,2000 | 15.324,5000 | 14.358,5000 | 17.382,2000 | 17.217 | ||||||
| Verbindlichkeiten gegenüber Kreditinstituten | 400 | 540 | 440 | 1.275 | 1.145 | ||||||
| Rückstellungen | 3.897,3000 | 3.262,3000 | 3.446 | 2.373,8000 | 2.666 | ||||||
| Verbindlichkeiten | 37.813,7000 | 38.673,7000 | 39.982,7000 | 44.037,1000 | 43.030 | ||||||
| Gezeichnetes Kapital | - | 2,6000 | 2,6000 | 2,6000 | 3 | ||||||
| Eigenkapital | 24.251,3000 | 23.044,1000 | 25.100,4000 | 26.502,9000 | 28.541 | ||||||
| Minderheitenanteile | - | - | - | - | - | ||||||
| Passiva, gesamt | 62.065 | 61.717,8000 | 65.083,1000 | 70.540 | 71.571 | ||||||
Gewinn- und Verlustrechnung
| 2014 US GAAP in Mio. USD |
2015 US GAAP in Mio. USD |
2016 US GAAP in Mio. USD |
2017 US GAAP in Mio. USD |
2018 US GAAP in Mio. USD |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Umsatzerlöse | 73.874,1000 | 79.156,5000 | 84.863 | 90.039,4000 | 92.105 | ||||||
| Abschreibungen (Gesamt) | 220,9000 | 230,1000 | 192,3000 | 168,4000 | 358 | ||||||
| Betriebsergebnis | 4.418,4000 | 4.753,1000 | 4.801,7000 | 4.175,4000 | 5.426 | ||||||
| Zinsergebnis | 600,7000 | -653 | -723 | -739 | -753 | ||||||
| Ergebnis vor Steuern | 4.368,1000 | 4.631 | 4.555,4000 | 3.963,8000 | 5.068 | ||||||
| Ertragsteuern | 1.808 | 2.071 | 2.085,6000 | 121 | 1.318 | ||||||
| Gewinnanteil Minderheitsgesellschafter | - | - | - | - | - | ||||||
| Konzernjahresüberschuss | 2.569,7000 | 2.560 | 2.469,8000 | 3.842,8000 | 3.750 | ||||||
Pro Aktie
Cash Flow
| 2014 US GAAP in Mio. USD |
2015 US GAAP in Mio. USD |
2016 US GAAP in Mio. USD |
2017 US GAAP in Mio. USD |
2018 US GAAP in Mio. USD |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash Flow aus laufender Geschäftstätigkeit | 3.369,3000 | 4.116 | 3.204,5000 | 4.184,8000 | 3.827 | ||||||
| Cash Flow aus Investitionstätigkeit | -974,9000 | -1.151,5000 | -513,9000 | -5.082,4000 | -1.259 | ||||||
| Cash Flow aus Finanzierungstätigkeit | -1.822,5000 | -2.997,4000 | -732,9000 | 426,9000 | -2.241 | ||||||
| Veränderung der liquiden Mittel | 564,8000 | -38,2000 | 1.961,8000 | -466,4000 | 325 | ||||||
| Anzahl der Mitarbeiter | 51.500 | 53.000 | 53.000 | 56.000 | 63.900 | ||||||
